Join Us at Biopharma Leadership & Innovation Conclave

#BLIConclave

The future of Biopharma: Made in India

8th October, 2025

10:00 AM - 8:00 PM

(Followed by Cocktails and Dinner)

Hilton Garden Inn Pune Hinjawadi

About the Event

Global health needs are changing fast. New challenges like complex diseases, rare conditions, and personalised treatments are transforming healthcare. At the same time, technology is changing how new therapies are discovered, developed, and delivered.

This shift opens a huge opportunity for biopharma in India. India has the talent, manufacturing strength and cost advantage to lead the next wave of biopharma innovation. However, to capture this potential, India must move faster, invest smarter, build strong partnerships, and build robust regulatory systems. To drive this transformation, Express Pharma is hosting the Biopharma Leadership Conclave, a platform to discuss how India can rise as a global leader in innovative, affordable biopharma, under the theme, 'The future of biopharma: Made in India'.To be held in Pune on October 8, 2025, it will bring together industry leaders, policymakers, researchers and investors to chart the roadmap for India’s growth in biopharma. The conclave will explore strategies to drive innovative, competitive and accessible biopharma solutions from India for the world. Read more

themes to be covered

Why India can lead the global biopharma revolution

From biosimilars to breakthroughs – India’s innovation pathway

Biopharma funding playbook

Manufacturing 4.0 in biopharma

Regulatory roadmap 2035: Fast tracking India’s biopharma future

Strengthening supply chains for biologics and biosimilars

Cell and gene therapy: India’s next big bet

Regulation meets quality: Accelerating safe, affordable biopharma

Accelerating talent-building for the biopharma industry

Formulating for next-gen biotherapeutics

Digitalisation and automation in biopharma: Keys to progress

Who should attend?

Biopharma companies manufacturing biosimilars, biologics, and cell and gene therapies.

Senior leaders from:

Manufacturing

Operations

Production

Research & Development (R&D)

Process development - Upstream and downstream

Quality (QA /QC)

Engineering & Technical

Fill & finish

Purchase/Procurement & Supply chain

Packaging

Regulatory Affairs

Government representatives from DBT, CSIR, BIRAC and other relevant agencies

Speakers

Mr Prasun Kumar Guha

Head & VP – Regulatory Affairs, Biologics, Dr Reddy’s Laboratories

Prof Samir Kulkarni

Head Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Mumbai

Mr Shrikrishna Chunekar

Director - QA, Serum Institute of India

Dr Anil Yadav

Technical Director, Raut Serums India

Mr Mukesh Patale

Group Lead-USP MSAT, Biologics Division, Dr Reddy’s Laboratories

Dr Sudeep Kumar

COO, TechInvention Lifecare

Dr Yashwant Chavan

MD, geneOmbio Technologies

Dr Venkata Ramana

Chief Scientific Officer, Reliance Life Sciences

Dr Mukesh Kumar

Chief Scientific Officer, CLINEXEL

Mr Usman Ali Ansari

Sr. Manager - Biotech Production, Bharat Serums and Vaccines (Mankind)

Mr Pankaj Gour

Sr General Manager, Enzene Biosciences

Ms Sonia Gandhi

DGM & Head (Regulatory Affairs & Policy Advocacy), BIRAC

Ms Sheetal Raut

Sr Manager & Bioassay Team Lead - Advanced Biotech Lab, Ipca Laboratories

Mr Vishal Pavitrakar

Senior Director Global Regulatory Affairs-CMC, Alvotech

Mr Jayachandran Ramalingam

GM, Head - Biosimilars QC, Serum Institute of India

Mr Shital Jain

DGM, Serum Institute of India

Mr Garet Jacob Fernandes

Product Manager, CSE India

Dr Shuvankar Ballav

Manager and Lead - Regulatory Affairs (ABL), Ipca Laboratories

Partners

Gold Partner
Silver Partner
Silver Partner
Silver Partner
Gold Partner
Silver Partner
Silver Partner
Silver Partner
Silver Partner
Silver Partner

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

Follow us

Copyright © The Indian Express [P] Ltd. All Rights Reserved.